Insulet Corporation, a leader in tubeless insulin pump technology with its Omnipod® brand, will participate in the Wells Fargo 2025 Healthcare Conference in Boston on September 4 at 3:00 p.m. Management will present at this event, and the live audio webcast and replay will be available on the Insulet Investor Relations website.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.